What was the market valuation for sacroiliitis in 2024?

The market valuation for sacroiliitis was $88.0 Million in 2024. Read More

What is the projected market valuation for sacroiliitis by 2035?

The projected market valuation for sacroiliitis is $248.5 Million by 2035. Read More

What is the expected CAGR for the sacroiliitis market during 2025 - 2035?

The expected CAGR for the sacroiliitis market during 2025 - 2035 is 9.9%. Read More

What are the main application segments in the sacroiliitis market?

Main application segments include Diagnostic Imaging, Functional Imaging, Cardiac Imaging, and Oncology Imaging. Read More

What was the valuation for Diagnostic Imaging in 2024?

The valuation for Diagnostic Imaging was $20.0 Million in 2024, projected to reach $55.0 Million by 2035. Read More

What types of MRI systems are included in the sacroiliitis market?

Types of MRI systems include Closed MRI Systems, Open MRI Systems, and Extremity MRI Systems. Read More

What is the projected valuation for High Field MRI by 2035?

The projected valuation for High Field MRI is $113.5 Million by 2035. Read More

Which end users are significant in the sacroiliitis market?

Significant end users include Hospitals, Diagnostic Imaging Centers, and Research Institutes. Read More

What was the valuation for Hospitals in 2024?

The valuation for Hospitals was $35.0 Million in 2024, expected to grow to $100.0 Million by 2035. Read More

South America Sacroiliitis Market

Q: Which companies are key players in the sacroiliitis market?

Key players in the sacroiliitis market include AbbVie Inc, Amgen Inc, Bristol-Myers Squibb Company, Johnson & Johnson, Novartis AG, Pfizer Inc, Roche Holding AG, Sanofi S.A., and UCB S.A. Read More

ID: MRFR/HC/55024-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

South America Sacroiliitis Market Research Report By Diagnosis (Imaging Tests, Anesthetic Injections), By Treatment (Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation), By End User (Hospitals, Diagnostic Centers) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

South America Sacroiliitis Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.9%

2024 Market Size$ 88 Million

2025 Market Size$ 96.71 Million

2035 Market Size$ 248.5 Million

Key Players

AbbVie Inc

Amgen Inc

Bristol-Myers Squibb Company

Johnson & Johnson

Novartis AG

Pfizer Inc

Trends

Rising Awareness and Education
Advancements in Treatment Options
Increased Healthcare Investment

Opportunities

Growing Prevalence of Sacroiliitis
Rising Demand for Personalized Medicine
Technological Innovations in Diagnostics

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Application (USD Million)
  1. 4.1.1 Diagnostic Imaging
  2. 4.1.2 Functional Imaging
  3. 4.1.3 Cardiac Imaging
  4. 4.1.4 Oncology Imaging
2. 4.2 Security, Access Control and Robotics, BY Type (USD Million)
  1. 4.2.1 Closed MRI Systems
  2. 4.2.2 Open MRI Systems
  3. 4.2.3 Extremity MRI Systems
3. 4.3 Security, Access Control and Robotics, BY Field Strength (USD Million)
  1. 4.3.1 Low Field MRI
  2. 4.3.2 Mid Field MRI
  3. 4.3.3 High Field MRI
4. 4.4 Security, Access Control and Robotics, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Diagnostic Imaging Centers
  3. 4.4.3 Research Institutes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 AbbVie Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Amgen Inc (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bristol-Myers Squibb Company (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Novartis AG (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Pfizer Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Roche Holding AG (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sanofi S.A. (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 UCB S.A. (BE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY TYPE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY FIELD STRENGTH
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
9. 6.9 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
12. 6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 (% SHARE)
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 (% SHARE)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY FIELD STRENGTH, 2024 (% SHARE)
17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY FIELD STRENGTH, 2024 TO 2035 (USD Million)
18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END USER, 2024 (% SHARE)
19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY FIELD STRENGTH, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Application (USD Million, 2025-2035)

Diagnostic Imaging
Functional Imaging
Cardiac Imaging
Oncology Imaging

Security, Access Control and Robotics By Type (USD Million, 2025-2035)

Closed MRI Systems
Open MRI Systems
Extremity MRI Systems

Security, Access Control and Robotics By Field Strength (USD Million, 2025-2035)

Low Field MRI
Mid Field MRI
High Field MRI

Security, Access Control and Robotics By End User (USD Million, 2025-2035)

Hospitals
Diagnostic Imaging Centers
Research Institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”